Peptide Permeability
Peptide Permeability - Related Videos
06:37
An Assay for Permeability of the Zebrafish Embryonic Neuroepithelium
0 Views •
Cited by 11 •
2012
We describe a live whole animal quantitative measurement for permeability of the embryonic zebrafish brain. The technique analyzes the ability to retain cerebrospinal fluid and molecules of different molecular weights within the neural tube lumen and quantifies their movement out of the ventricles. This method is useful for determining differences in epithelial permeability and maturation during development and disease.
04:00
Immunoaffinity Based Extraction of Ubiquitinylated Peptides: A Technique to Selectively Extract Ubiquitin Tagged Peptides from Purified Peptide Fractions
0 Views •
2023
This video describes a method to extract and purify ubiquitinylated peptides containing remnant di-glycine peptides from a complex peptide mixture. The presented method may help in identifying original ubiquitination sites in the protein.
07:03
An in vivo Assay to Test Blood Vessel Permeability
0 Views •
Cited by 335 •
2013
We are presenting an in vivo assay to test blood vessel permeability. This assay is based on intravenous injection of a dye and subsequent visualization of its diffusion into interstitial spaces.
14:28
Peptide-based Identification of Functional Motifs and their Binding Partners
0 Views •
Cited by 2 •
2013
Techniques to dissect the mechanisms underlying the secretion of HIV-1 Nef in exosomes are described. Specific short peptides derived from Nef and protein transfection were exploited to determine the structure, function, and binding partners of Nef’s Secretion Modification Region. These procedures have general relevance in many mechanistic studies.
01:25
Permeability of Concrete
0 Views •
2024
Permeability in the context of concrete refers to how easily liquids or gases can pass through the material. This quality is crucial for assessing the water-tightness and durability of concrete structures and their resistance to chemical attacks. Concrete permeability can be determined through comparative laboratory tests. These tests typically involve sealing a concrete specimen from the sides, applying water pressure to the top surface with pressure, and measuring the amount of water passing...
FAQs
Size, charge, hydrophobicity, and sequence jointly shape peptide movement across a barrier. Molecular size can affect whether a peptide approaches or traverses the membrane efficiently, while charge and hydrophobicity influence its interaction with membrane components. Sequence adds another layer because it determines the peptide’s overall chemical properties. Considering these variables together supports rational peptide design.
Three routes can contribute to peptide uptake: passive diffusion, transporter-mediated uptake, and endocytosis. Passive diffusion depends on the peptide’s ability to move through the barrier without a listed transport process. Transporter-mediated uptake uses available cellular pathways, whereas endocytosis brings material into cells through cellular uptake. Distinguishing these routes helps explain how a peptide reaches intracellular targets.
Peptide permeability is not determined by the molecule alone; the barrier also matters. Membrane composition can change how a sequence, charge pattern, or hydrophobic character interacts with the barrier, and epithelial layers present a distinct setting from cell membranes. Comparing the same peptide across barriers can therefore reveal why access varies between tissues or delivery goals.
Researchers use these studies to assess whether a peptide can reach the biological location required for treatment. Results can identify limited membrane or epithelial access, guide changes to peptide design or formulation, and support development of delivery systems. The practical outcome is a clearer connection between barrier crossing, tissue access, and potential therapeutic effectiveness.
These studies can inform oral, transdermal, and intracellular delivery strategies. Oral assessment focuses on access across epithelial barriers, transdermal assessment concerns movement through skin-related barriers, and intracellular assessment asks whether peptides can enter cells. Examining these goals helps researchers match a peptide or delivery system to the tissue access required for its intended use.
Optimization requires considering permeability together with the peptide’s biological activity. Researchers can adjust peptide design, formulation, or delivery systems to improve tissue access, but the goal is not simply greater barrier crossing. A useful strategy must preserve the peptide’s activity while addressing the specific membrane or epithelial limitation that restricts therapeutic effectiveness.